Drug allergy and the development of nephropathies in children
Lagutina, L.E.; Solov'eva, V.I.; Maneshina, O.A.; Kubalik, N.V.
Pediatriia 4: 41
1985
ISSN/ISBN: 0031-403X PMID: 4000826 Document Number: 260341
Document emailed within 1 workday
Related Documents
Manin, V.N. 1981: Drug allergy in children (2. its diagnosis, treatment and prevention) Fel'dsher i Akusherka 46(10): 20-23Manin, V.N. 1981: Drug allergy in children (1. Etiology, pathogenesis and clinical aspects) Fel'dsher i Akusherka 46(9): 17-23
Dworzynski, K.; Ardern-Jones, M.; Nasser, S.; Ardern-Jones, M.; Chong, L.Yee.; Constanti, M.; Cousins, D.; deMott, K.; Diaz, T.; Doyle, M.; Toit, G.Du.; Dworzynski, K.; East, M.; Ewan, P.; Harker, M.; Kelley, K.; Larcombe, J.; Marsden, G.; Mundy, N.; Nasser, S.; Osborne, A.; Park, S.; Pollit, V.; Ritchie, G.; Sharpin, C.; Whittaker, P.; Williams, A. 2014: Diagnosis and management of drug allergy in adults, children and young people: summary of NICE guidance Bmj 349: G4852
Lepoutre, E. 1976: Acute drug-induced tubulo-interstitial nephropathies Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 21(8): 685-689
Fillastre, J.P.; Legallicier, B.; Godin, M.; Le Roy, F. 1997: Interstitial nephropathies of toxic or drug origin. new causes, new prospects Presse Medicale 26(10): 477-484
Krzyszkowska, A.; Leowski, J.; Górski, S.; Iwanowa, O.; Lenkiewicz, B.; Michalowicz, Z.; Szumilak, I.; Wasowska, J. 1977: Tuberculin allergy in children vaccinated with BCG for the 1st time and in revaccinated children. II. Tuberculin allergy in school children Pneumonologia Polska 45(5): 369-376
Tang, R.B.; Wu, K.K. 1989: Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children Annals of Allergy 62(5): 432-435
Ganiev, M.G. 1984: Medical support for children with nephropathies Sovetskoe Zdravookhranenie 4: 48-52
Schneer, J.H.; Chipail, A.; Constantinescu, V.; Brumăr, O.M. 1973: Anticoagulant treatment in glomerular nephropathies in children Pediatria 22(1): 69-73
Dubasova, E.P. 1971: Blood vitamin K content in children with nephropathies Voprosy Okhrany Materinstva i Detstva 16(7): 91
Degtiareva, E.M.; Kharina, E.A.; Bosin, V.I.; Skripkina, L.A. 1981: Embryonic dysgenesis stigmata in children with nephropathies Pediatriia 4: 14-20
Laterza, G.; Clemenzia, G.; Russo, G.; Scibinetti, F.; Gentile, V. 1984: Enzymuria in chronic nephropathies. Diagnosis by the urinary enzyme method in chronic nephropathies Minerva Medica 75(27): 1617-1622
Kukhtevich, A.V.; Ermolenko, V.M.; Bunatian, A.F.; Gitel', E.P.; Smirnova, G.A. 1989: Zinc and parlodel: the treatment potentials for retardation of growth and sexual development in nephropathies in adolescents Terapevticheskii Arkhiv 61(10): 106-112
Gargah, T.; Gharbi, Y.; Ben Moussa, M.; Lakhoua, M.R. 2010: Uropathies and nephropathies of Bardet-Biedl syndrome in children La Tunisie Medicale 88(10): 737-741
Lebedev, V.P.; Akchurin, A.Z.; Martynov, S.M.; Melent'eva, G.A.; Terekhina, N.E. 1977: Experience with work in local sanatorium for preschool children with nephropathies Pediatriia 2: 60-62
Adamson, P.C. 2017: Challenges in drug development for children Clinical Advances in Hematology and Oncology: H&o 15(1): 26-29
Dmitrieva, T.I.; Aĭzman, R.I.; Kŏsolapov, G.K.; Peterson, V.D. 1990: Structural and functional status of the kidneys in children with nephropathies associated with metabolic disorders Pediatriia 2: 31-36
Salazar, A.C.; López, E.; Vargas, R. 1980: Evaluation of nephropathies in children with rheumatoid arthritis and prolonged therapy with salicylates Boletin Medico del Hospital Infantil de Mexico 37(2): 333-343
Savilahti, E.; Tainio, V.M.; Salmenperä, L.; Arjomaa, P.; Kallio, M.; Perheentupa, J.; Siimes, M.A. 1991: Levels of IgA and cow milk antibodies in breast milk vs. the development of atopy in children. Low colostral IgA associated with cow milk allergy Advances in Experimental Medicine and Biology 310: 417-425
Whitehouse, P.J.; Sciulli, C.G.; Mason, R.M. 1997: Dementia drug development: use of information systems to harmonize global drug development Psychopharmacology Bulletin 33(1): 129-133